TAK-242 ameliorates contact dermatitis exacerbated by IL-36 receptor antagonist deficiency

Sci Rep. 2020 Jan 20;10(1):734. doi: 10.1038/s41598-020-57550-5.

Abstract

Loss-of-function mutations in IL36RN cause generalized pustular psoriasis (GPP), which is characterized by neutrophil-infiltrated lesions. Neutrophils are important during contact hypersensitivity in mice. However, it has never been determined whether interleukin-36 receptor antagonist (IL-36Ra) deficiency is an exacerbating factor in contact dermatitis. We examined whether a loss-of-function IL36RN mutation exacerbates contact dermatitis and evaluated the changes in contact dermatitis-related cytokines. Wild-type and Il36rn-/- mice were treated with 1-fluoro-2,4-dinitorobenzene (DNFB) and evaluated for ear thickness, histopathological features, numbers of infiltrated neutrophils, and numbers of CD4 + and CD8 + T cells. Furthermore, mRNA levels of contact dermatitis-related cytokines were measured by real-time polymerase chain reaction, and effects of TAK-242, a toll-like receptor 4 (TLR4) inhibitor, on the contact hypersensitivity (CHS) response were evaluated. We found that the ear thickness, cytokine expression, and neutrophil infiltration significantly increased in Il36rn-/- mice compared with that in wild-type mice. TAK-242 alleviated CHS and prevented neutrophil infiltration, cytokine expression, and ear thickening in Il36rn-/- mice. These data indicate that Il36rn-/- mutations are an exacerbating factor for CHS and that TAK-242 can reduce the inflammatory responses that are associated with the CHS response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD4-CD8 Ratio
  • Cytokines / metabolism
  • Dermatitis, Contact / drug therapy*
  • Dermatitis, Contact / etiology
  • Dermatitis, Contact / genetics*
  • Dermatitis, Contact / immunology
  • Dinitrofluorobenzene / adverse effects
  • Interleukins / deficiency*
  • Loss of Function Mutation
  • Mice, Transgenic
  • Neutrophil Infiltration / drug effects
  • Sulfonamides / pharmacology*
  • Sulfonamides / therapeutic use*
  • Toll-Like Receptor 4 / antagonists & inhibitors

Substances

  • Cytokines
  • IL36RN protein, human
  • Interleukins
  • Sulfonamides
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate
  • Dinitrofluorobenzene